Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan

Hepatology Research

Volumn 40, Issue 10, 2010, Pages 989-996

  Nakano, Masahito ^a   Ando, Eiji ^b   Kuromatsu, Ryoko ^a   Torimura, Takuji ^a   Sumie, Shuji ^a   Takata, Akio ^a   Fukushima, Nobuyoshi ^a   Kurogi, Junichi ^a   Niizeki, Takashi ^a   Iwamoto, Hideki ^a   Tanaka, Masatoshi ^c   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Inoue Hospital   (Japan)

^c KURUME UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Carcinoma; Cirrhosis; Hepatocellular surveillance; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENTAL FINDING; JAPAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM;

EID: 77957239591     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00706.x     Document Type: Article

References (27)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-6.
2. Fattovich G, Giustina G, Degos F. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997, 112:463-72.
3. Colombo M, de Franchis R, Del Ninno E. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991, 325:675-80.
4. Oka H, Kurioka N, Kim K. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990, 12:680-7.
5. Ikeda K, Saitoh S, Koida I. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993, 18:47-53.
6. Tsukuma H, Hiyama T, Tanaka S. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993, 328:1797-801.
7. Sangiovanni A, Del Ninno E, Fasani P. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004, 126:1005-14.
8. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000, 31:330-5.
9. Trevisani F, Cantarini MC, Labate AM. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. Am J Gastroenterol 2004, 99:1470-6.
10. Mok TS, Yeo W, Yu S. An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results. J Clin Oncol 2005, 23:8041-7.
11. Bruix J, Llovet JM. HCC surveillance: who is the target population? Hepatology 2003, 37:507-9.
12. Trevisani F, Santi V, Gramenzi A. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis? Am J Gastroenterol 2007, 102:2448-57. quiz 58
13. Ando E, Kuromatsu R, Tanaka M. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease. J Clin Gastroenterol 2006, 40:942-8.
14. Bolondi L, Sofia S, Siringo S. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001, 48:251-9.
15. Pateron D, Ganne N, Trinchet JC. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994, 20:65-71.
16. Bruix J, Sherman M, Llovet JM. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001, 35:421-30.
17. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators. Hepatology 2000, 31:840-5.
18. Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 2004, 10:S115-20.
19. Kudo M, Chung H, Haji S. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology 2004, 40:1396-405.
20. Mazzaferro V, Regalia E, Doci R. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334:693-9.
21. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann Surg 1990, 211:277-87.
22. Shiina S, Teratani T, Obi S. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005, 129:122-30.
23. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999, 210:655-61.
24. Muto Y, Sato S, Watanabe A. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005, 3:705-13.
25. Marchesini G, Bianchi G, Merli M. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 2003, 124:1792-801.
26. Mazzaferro V, Romito R, Schiavo M. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology 2006, 44:1543-54.
27. Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Kinoshita H. Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy. Br J Surg 2002, 89:418-22.